Acta Psychiatrica Scandinavica

Acta Psychiatrica Scandinavica is a peer-reviewed medical journal focusing on clinical and translational research in psychiatric disorders. Founded in the interwar period in Scandinavia, the journal has published original research, reviews, and clinical reports that intersect with major developments in psychiatry, neurology, and public health. Over decades it has featured contributions from figures and institutions across Europe and North America, reflecting shifts in diagnostic systems and therapeutic approaches.

History

The journal was established in 1926 during a period marked by the influence of figures such as Emil Kraepelin, Sigmund Freud, Alois Alzheimer, Eugen Bleuler, and institutions including the Karolinska Institutet, University of Oslo, Uppsala University, University of Copenhagen, and Lund University Hospital. Early volumes addressed topics connected with the aftermath of World War I, debates prompted by the Treaty of Versailles, and the growth of national psychiatric services in Sweden, Norway, and Denmark. In the 1930s and 1940s the journal engaged with research by authors associated with the Munich Psychiatric Clinic, the Vienna Psychoanalytic Society, and the Johns Hopkins Hospital, as psychiatry worldwide responded to advances in neuropathology exemplified by work at the Charité – Universitätsmedizin Berlin and the Pasteur Institute. Post‑World War II expansion saw contributions from researchers affiliated with the National Institute of Mental Health, the Maudsley Hospital, and the Institute of Psychiatry, London. During the latter half of the twentieth century, the journal reflected paradigm shifts linked to the editions of the Diagnostic and Statistical Manual of Mental Disorders and the International Classification of Diseases, while publishing studies by investigators from the University of Cambridge, University of Oxford, King's College London, Harvard Medical School, Yale School of Medicine, and the University of Toronto.

Scope and Content

The journal's remit covers clinical studies, epidemiology, psychopharmacology, neuroimaging, and genetic research, drawing submissions from centers such as Massachusetts General Hospital, the Mayo Clinic, the Broad Institute, and the Max Planck Institute for Psychiatry. Typical topics reported include trials of antidepressants associated with work at Roche Pharmaceuticals, antipsychotic studies linked to GlaxoSmithKline, neurobiological investigations using techniques developed at Cold Spring Harbor Laboratory and Stanford University School of Medicine, and population research paralleling cohorts from the Framingham Heart Study and the Rotterdam Study. Reviews and meta-analyses often cite methodologies refined at the Cochrane Collaboration, the World Health Organization, and the European Medicines Agency. The journal has also published clinical case series informed by practices at the Sheppard Pratt Health System, the Beth Israel Deaconess Medical Center, and the Royal College of Psychiatrists.

Editorial Structure and Policies

Editorial leadership has historically included editors with affiliations to the Karolinska Institutet, University of Gothenburg, and University of Oslo, working alongside editorial boards composed of scholars from institutions like the University of Helsinki, University of Bergen, Trinity College Dublin, University College Dublin, McGill University, and the University of British Columbia. The peer review process follows standards advocated by the Committee on Publication Ethics and editorial policies consonant with publishers such as Wiley-Blackwell and professional bodies such as the European Psychiatric Association. Conflicts of interest and data sharing statements align with recommendations from the International Committee of Medical Journal Editors and the Declaration of Helsinki. Special issues and thematic series have been coordinated with learned societies including the Scandinavian Psychiatric Association and collaborations with research networks like the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance.

Abstracting and Indexing

The journal is indexed in major bibliographic databases such as Index Medicus, MEDLINE, PubMed Central, Embase, PsycINFO, and the Science Citation Index. Citation records are tracked by services like Clarivate Analytics (formerly Thomson Reuters), Scopus operated by Elsevier, and bibliometric analyses reference metrics used by Journal Citation Reports and the Eigenfactor Project. Library holdings appear in catalogues managed by the Library of Congress, the British Library, and national repositories in Sweden, Norway, and Denmark.

Impact and Reception

Throughout its history the journal has influenced clinical practice and academic discourse, publishing work cited by guideline committees at the National Institute for Health and Care Excellence, the American Psychiatric Association, and the Royal Australian and New Zealand College of Psychiatrists. High-impact articles have been referenced in policy reports produced by the European Commission, the Organisation for Economic Co-operation and Development, and the United Nations agencies concerned with mental health. The journal's articles have been critiqued and discussed in venues including the Lancet, The New England Journal of Medicine, BMJ, and specialty outlets such as Schizophrenia Bulletin and Biological Psychiatry. Citation metrics show variable impact across decades, with notable contributions from researchers affiliated with the University of Edinburgh, King's College London, Columbia University Irving Medical Center, Johns Hopkins Bloomberg School of Public Health, and the Imperial College London.

Category:Psychiatry journals